What it is: InstaMed's Thymosin Alpha-1 Sublingual Oral Strip delivers 500 mcg of high-purity Thymosin Alpha-1 (Tα1) per strip via proprietary InstaRelease® buccal transmucosal delivery technology — a needle-free, pre-dosed sublingual dissolving format enabling direct mucosal absorption without first-pass hepatic metabolism. Thymosin Alpha-1 is a 28-amino acid peptide originally isolated from the thymus gland — the primary organ of T-cell maturation and immune education — with an extensive research profile across immune modulation, antiviral defense, inflammation regulation, and antioxidant support. Each strip is third-party CoA-verified at 99.75% purity by HPLC. Exclusively practitioner-directed.
How it works: Thymosin Alpha-1 supports immune resilience through T-cell maturation, dendritic cell activation, and cytokine regulation. It promotes the differentiation and activation of CD4+ helper T-cells, CD8+ cytotoxic T-cells, and NK cells — the primary effector cells of antiviral and antitumor immune surveillance — through TLR (Toll-like receptor) signaling pathway enhancement and dendritic cell maturation support. Tα1 modulates the Th1/Th2 cytokine balance — promoting IFN-γ and IL-2 production to support Th1-dominant antiviral immunity while simultaneously suppressing excessive inflammatory cytokine output — making it relevant for both immune deficiency and chronic inflammatory immune dysregulation presentations. It additionally activates the Nrf2 antioxidant pathway, supporting cellular antioxidant defense and mitochondrial integrity under oxidative stress. InstaRelease® buccal strip delivery enables transmucosal Tα1 absorption — bypassing the GI peptide degradation that limits conventional oral delivery — for needle-free systemic immune peptide support.
When to use it: Indicated for adults in practitioner-directed protocols requiring immune resilience support — including post-viral immune recovery, chronic infection immune burden, immune dysregulation, autoimmune inflammatory balance, and age-related immune decline. One strip sublingually 5 days per week with 2 days off. Optimal protocol duration is 4–8 weeks. Not recommended during pregnancy or breastfeeding. Consult a healthcare practitioner before use if taking immunosuppressant medications or managing an autoimmune condition.
Serving Size: 1 Strip
Servings Per Container: 20
Suggested Use: Place one strip on the tongue and allow it to dissolve, then swallow. Take 1 strip daily, 5 days per week with 2 days off. A 4–8 week cycle is optimal, or as directed by your healthcare practitioner.
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| Calories | 0 | — |
| Calories from Fat | 0 | — |
| Total Fat | 0 | 0% |
| Thymosin Alpha-1 | 500 mcg | † |
† Daily Value not established.
Other Ingredients: Pullulan, β-cyclodextrin, stevia, vegetable glycerin, orange flavor extract, xanthan gum, arabic gum, citric acid, sunflower lecithin, annatto seeds (color).
Caution: Not recommended during pregnancy or breastfeeding. Use with caution and under practitioner supervision in clients taking immunosuppressant medications or managing autoimmune conditions, as Thymosin Alpha-1 modulates immune cell activity. Consult your healthcare practitioner before use if managing any medical condition or taking medications. For adult use only. Keep out of reach of children. Store in a cool, dry place away from direct sunlight and excessive heat. Do not use if inner seal is broken or missing.
✓ Gluten Free ✓ Soy Free ✓ Non-GMO ✓ Needle-Free ✓ Third-Party CoA Verified ✓ No Artificial Colors or Flavors
Key Ingredients:
Thymosin Alpha-1 (Tα1) — 500 mcg Thymosin Alpha-1 is a 28-amino acid peptide (Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn) originally isolated from the thymus gland's thymosin fraction 5 by Dr. Allan Goldstein in the 1970s, and since extensively studied in multiple clinical contexts including hepatitis B, hepatitis C, HIV, influenza, and cancer immunotherapy — delivered here at 500 mcg per strip with third-party CoA verification of 99.75% purity by HPLC and full conformance across heavy metals and microbial specifications. Tα1 supports immune function through TLR2 and TLR9 signaling activation on dendritic cells and macrophages — driving dendritic cell maturation and antigen presentation capacity, promoting CD4+ T-helper and CD8+ cytotoxic T-lymphocyte differentiation and activation, enhancing NK cell cytotoxic activity, and supporting Th1 cytokine polarization through IFN-γ and IL-2 upregulation — while simultaneously modulating excessive pro-inflammatory cytokine output to support balanced rather than hyperactivated immune responses. Tα1 additionally activates the Nrf2/HO-1 antioxidant pathway, supporting cellular antioxidant enzyme upregulation and mitochondrial integrity under the oxidative stress that accompanies viral infection, immune overactivation, and chronic inflammatory burden — delivered via InstaRelease® buccal transmucosal technology for needle-free systemic peptide bioavailability.
InstaRelease® Delivery Technology (Buccal Transmucosal Strip Matrix) — per strip The InstaRelease® oral dissolving strip matrix delivers Thymosin Alpha-1 through the buccal and sublingual mucosa directly into systemic circulation — bypassing the GI proteolytic degradation that renders conventional oral peptide delivery ineffective at meaningful systemic concentrations. Engineered from pullulan film base, β-cyclodextrin for peptide solubilization and mucosal contact optimization, and an orange-flavored annatto-colored sensory matrix, each individually sealed strip dissolves within seconds of sublingual placement — providing consistent, pre-dosed Tα1 delivery in a format requiring no injection, no water, no refrigeration for travel, and no compliance barriers associated with injectable immune peptide protocols. The 5-days-on, 2-days-off cycle mirrors the pulsatile dosing rhythm used in injectable Tα1 research protocols, adapted here for practitioner-directed oral strip delivery.
